NON-HODGKINS LYMPHOMA
Clinical trials for NON-HODGKINS LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKINS LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKINS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise against tough blood cancers
Disease control Recruiting nowThis study tests an oral drug called MK-1026 (nemtabrutinib) in about 490 people with certain blood cancers, including chronic lymphocytic leukemia, non-Hodgkin lymphoma, and Waldenström's macroglobulinemia. The main goals are to check safety and see how well the drug shrinks or …
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug duo targets stubborn blood cancers in early trial
Disease control Recruiting nowThis study tests two experimental drugs, APG-115 and APG-2575, in people with T-cell prolymphocytic leukemia (T-PLL) or non-Hodgkin's lymphoma (NHL) that has come back or stopped responding to treatment. The main goal is to find the safest dose and see how well the drugs work. Ab…
Matched conditions: NON-HODGKINS LYMPHOMA
Phase: PHASE2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC